Bicara Therapeutics Inc (BCAX) PT Raised to $18 at Goldman Sachs
Tweet
Share
E-mailGet Alerts BCAX Hot Sheet
Price: $24.28 +2.75%
Rating Summary:
13 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
13 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Goldman Sachs analyst Richard Law raised the price target on Bicara Therapeutics Inc (NASDAQ: BCAX) to $18.00 (from $16.00) while maintaining a Neutral rating.
You May Also Be Interested In
- Bicara Therapeutics Inc (BCAX) PT Raised to $23 at Wells Fargo
- Lithium Ionic Corp (LTH:CN) PT Lowered to Cdn$2.50 at Desjardins
- LG Electronics India (LGEL:IN) PT Raised to INR1,815 at ICICI Securities
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
